Bioxytran Inc. Announces Appointment of Ex Bristol-Myers Squibb Executive to Scientific Advisory Board

NEXT STORY
Onconova Therapeutics Announces Presentations at the 15th International Symposium on Myelodysplastic Syndromes (MDS 2019) in Copenhagen, Denmark
PREV STORY
Zynerba Pharmaceuticals Receives Fast Track Designation for Zygel™ for the Treatment of Behavioral Symptoms Associated with Fragile X Syndrome (FXS)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

resTORbio Appoints Jeffrey Chodakewitz, M.D., to its Board of Directors

Brings extensive experience in clinical and pipeline development to resTORbio’s BoardBOSTON, Aug. 15, 2018 ...

author_avatar
NASDAQ Market News

Global Medical Marijuana Market 2021, Size & Share | Market Worth USD 178.95 Billion with 5.7% CAGR by 2026

author_avatar
NASDAQ Market News

TFF Pharmaceuticals Receives Approval from Health Canada to Enter Human Clinical Trials for Inhaled Formulation of Niclosamide to Treat COVID-19

author_avatar
NASDAQ Market News